Fairmount Funds Management LLC sold SYRE
June 23, 2026 · Form 4 insider transaction
Fairmount Funds Management LLC sold 4,684,781 shares of Spyre Therapeutics, Inc. at $85.31 per share, a transaction worth $399.66M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,684,781
Price
$85.31
Total value
$399.66M
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 23, 2026
Filing dateJune 23, 2026
Shares owned after0
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund II L.P. The managers of Fairmount are Peter Harwin and Tomas Kiselak. Fairmount, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.